zydus cadila

Portland, OR, Nov. 01, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Chronic Hepatitis B (CHB) Market size was estimated at $4.6 billion…

Pharmaceutical company Zydus group on Wednesday announced that it had started the supply of its COVID-19 vaccine, ZyCoV-D, to the Central government against their order. The group is also…

The vaccine is a three-dose one administered intradermally using the painless PharmaJet, a needle-free system, Tropis, on Day 0, Day 28 and Day 56. Zydus Cadila on Wednesday announced that…

Nasal vaccine is administered through the nose and not syringe making it easy for application to children. It can generate an immune response at the site of infection within respiratory…

India has placed an order for 10 million doses of Zydus Cadila's DNA COVID-19 vaccine at a price of Rs 265 per dose,…

By Aarushi BatraAs the Drugs Controller General of India (DCGI) granted Emergency Use Authorization (EUA) to Zydus Cadila’s ZyCoV-D vaccine and Subject Expert Committee (SEC) recommended…

Bharat Biotech thanked the DCGI, SEC and CDSCO for expediting the review process. (Representational image)The vaccine Subject Expert Committee (SEC) on Tuesday recommended granting of…

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D,…

Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI)…

A total of 90 children were subjected to Covaxin trials in Karnataka. ‘Zydus Cadila, a leading pharmaceutical company in India was recently authorized by DCGI for its needle-free ZyCoV-D…